Twitter | Search | |
Search Refresh
dermPA 15 Nov 14
is sponsoring our Breakfast and Product Theater this morning at in .
Reply Retweet Like
KantorNeurology Feb 10
News: Dr.Reddy's U.S. FDA approved for acute migraine treatment — nasal spray -
Reply Retweet Like
DataGroup Asia 8 Mar 16
Reply Retweet Like
EvCurlGurl (Evelyn) 4 Dec 13
Editor gathering with Jim Crawford, for PROMIUS Pharma @ The Four Seasons Restaurant
Reply Retweet Like
dermPA 20 Oct 15
: the promise steps in - (via )
Reply Retweet Like
Dr. Reddy's 28 Jun 18
, our US subsidiary, announced its poster and platform presentations for the 60th Annual Scientific Meeting of the American Headache Society in San Francisco, CA. To view the full list of presentations, visit
Reply Retweet Like
H Alexander Krob MD Mar 26
Another nasal spray: and announce approval of () nasal spray () for acute / intervention treatment of attacks!
Reply Retweet Like
Plexus Ventures Oct 3
Reply Retweet Like
Drug Delivery Forum 2 Apr 18
and file NDA for novel intranasal migraine candidate. "The filing of DFN-02 NDA represents our continuing commitment to bring innovative solutions in migraine treatment,” Dr. Namboodiripad, Promius Pharma
Reply Retweet Like
MedGenera 2 Apr 18
#2018 is a crucial year for development. Reducing side effects. . Many novel in line for first approval.
Reply Retweet Like